ARS Pharmaceuticals Inc (SPRY) PT Raised to $32 at Raymond James
Tweet Send to a Friend
Raymond James analyst Ryan Deschner raised the price target on ARS Pharmaceuticals Inc (NASDAQ: SPRY) to $32.00 (from $28.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
